NATCO PHARMA USA LLC – Trademark Portfolio
Entity Type: 16
NATCO PHARMA USA LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include NATCO, DASH DOSE, NATCO PHARMA USA, N NATCO PHARMA USA, and DASH PHARMACEUTICALS. The owner is based in UPPER SADDLE RIVER, NJ.
2 PARK WAY
UPPER SADDLE RIVER, NJ 07458
Showing of trademarks Trademarks
Trademark Classifications
NATCO PHARMA USA LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NATCO PHARMA USA LLC have?
NATCO PHARMA USA LLC has 11 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 abandoned, 1 cancelled.
What trademark classes does NATCO PHARMA USA LLC file in?
NATCO PHARMA USA LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NATCO PHARMA USA LLC's most well-known trademarks?
NATCO PHARMA USA LLC's registered trademark portfolio includes well-known marks such as NATCO, DASH DOSE, NATCO PHARMA USA, N NATCO PHARMA USA, and DASH PHARMACEUTICALS. These are among 9 currently registered trademarks in the portfolio.
What is NATCO PHARMA USA LLC's trademark registration success rate?
NATCO PHARMA USA LLC has a 82% trademark registration rate, with 9 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.